Prof. Dr. med. Pietro Vernazza
Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
Lubomirov R, Telenti A, Günthard H, Furrer H, Vernazza P, Elzi L, Bernasconi E, Hirschel B, Cavassini M, Martinez R, Ledergerber B, di Iulio J, Colombo S, the Swiss HIV Cohort Study. Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study. J Infect Dis 2010; 203:246-257.
09.12.2010Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
09.12.2010J Infect Dis 2010; 203:246-257
Lubomirov Rubin, Telenti Amalio, Günthard Huldrych F, Furrer Hansjakob, Vernazza Pietro, Elzi Luigia, Bernasconi Enos, Hirschel Bernard, Cavassini Matthias, Martinez Raquel, Ledergerber Bruno, di Iulio Julia, Colombo Sara, the Swiss HIV Cohort Study
Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
Magenta L, Bernasconi E, Bucher H, Decosterd L, Cavassini M, Evison J, Vernazza P, Hirschel B, Flepp M, Hasse B, Young J, Richter W, Dell-Kuster S, the Swiss HIV Cohort Study (SHCS). Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy. AIDS Res Hum Retroviruses 2010
22.11.2010Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
22.11.2010AIDS Res Hum Retroviruses 2010
Magenta L, Bernasconi E, Bucher H C, Decosterd L A, Cavassini M, Evison J, Vernazza Pietro, Hirschel B, Flepp M, Hasse B, Young J, Richter W O, Dell-Kuster S, the Swiss HIV Cohort Study (SHCS)
Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals
Rotger M, Tarr P, Telenti A, Egger M, Ledergerber B, Weber R, Furrer H, Hirschel B, Bernasconi E, Cavassini M, Vernazza P, Elzi L, Taffé P, Martinez R, Gsponer T, Swiss HIV Cohort Study. Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals. Clin Infect Dis 2010; 51:1090-8.
01.11.2010Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals
01.11.2010Clin Infect Dis 2010; 51:1090-8
Rotger Margalida, Tarr Philip E, Telenti Amalio, Egger Matthias, Ledergerber Bruno, Weber Rainer, Furrer Hansjakob, Hirschel Bernard, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Elzi Luigia, Taffé Patrick, Martinez Raquel, Gsponer Thomas, Swiss HIV Cohort Study
Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study
Hasse B, Weber R, Nicca D, Bernasconi E, Cavassini M, Elzi L, Evison J, Jeannin A, Glass T, Vernazza P, Hirschel B, Ledergerber B, Swiss HIV Cohort Study. Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2010; 51:1314-22.
29.10.2010Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study
29.10.2010Clin Infect Dis 2010; 51:1314-22
Hasse Barbara, Weber Rainer, Nicca Dunja, Bernasconi Enos, Cavassini Matthias, Elzi Luigia, Evison John-Marc, Jeannin Andre, Glass Tracy R, Vernazza Pietro, Hirschel Bernard, Ledergerber Bruno, Swiss HIV Cohort Study
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
Young J, Bucher H, Battegay M, Hirschel B, Vernazza P, Bernasconi E, Cavassini M, Fux C, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard H, Scherrer A, for the Swiss HIV Cohort Study. Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Med 2010
18.10.2010Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
18.10.2010HIV Med 2010
Young J, Bucher Hc, Battegay M, Hirschel B, Vernazza Pietro, Bernasconi E, Cavassini M, Fux Ca, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard Hf, Scherrer Au, for the Swiss HIV Cohort Study
Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study(*)
Ledergerber B, Weber R, Rickenbach M, Furrer H, Hirschel B, Vernazza P, Bernasconi E, Battegay M, Cavassini M, and the Swiss HIV Cohort Study (SHCS). Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study(*). HIV Med 2010
18.10.2010Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study(*)
18.10.2010HIV Med 2010
Ledergerber B, Weber R, Rickenbach M, Furrer H, Hirschel B, Vernazza Pietro, Bernasconi E, Battegay M, Cavassini M, and the Swiss HIV Cohort Study (SHCS)
B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-? response to TLR9 triggering
Audigé A, Schlaepfer E, von Wyl V, Miller R, Vernazza P, Nadal D, Speck R, SHCS. B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-? response to TLR9 triggering. AIDS Res Hum Retroviruses 2010; 26:1063-74.
01.10.2010B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-? response to TLR9 triggering
01.10.2010AIDS Res Hum Retroviruses 2010; 26:1063-74
Audigé Annette, Schlaepfer Erika, von Wyl Viktor, Miller Regina C, Vernazza Pietro, Nadal David, Speck Roberto F, SHCS
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load
Alizon S, Bonhoeffer S, Günthard H, Telenti A, Bürgisser P, Battegay M, Bernasconi E, Vernazza P, Rauch A, Furrer H, Klimkait T, Shah C, Böni J, Hirschel B, Yerly S, Kouyos R, Stadler T, von Wyl V, Swiss HIV Cohort Study. Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathog 2010; 6
30.09.2010Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load
30.09.2010PLoS Pathog 2010; 6
Alizon Samuel, Bonhoeffer Sebastian, Günthard Huldrych F, Telenti Amalio, Bürgisser Philippe, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Rauch Andri, Furrer Hansjakob, Klimkait Thomas, Shah Cyril, Böni Jürg, Hirschel Bernard, Yerly Sabine, Kouyos Roger D, Stadler Tanja, von Wyl Viktor, Swiss HIV Cohort Study
Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir
Gutmann C, Vernazza P, Yerly S, Cavassini M, Decosterd L, Hirschel B, Fux C, Günthard H, Cusini A, Swiss HIV Cohort Study (SHCS). Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir. AIDS 2010; 24:2347-54.
24.09.2010Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir
24.09.2010AIDS 2010; 24:2347-54
Gutmann Christine, Vernazza Pietro, Yerly Sabine, Cavassini Matthias, Decosterd Laurent-Arthur, Hirschel Bernard, Fux Christoph, Günthard Huldrych F, Cusini Alexia, Swiss HIV Cohort Study (SHCS)
Low Postseroconversion CD4 Count and Rapid Decrease of CD4 Density Identify HIV(+) Fast Progressors
Audigé A, Taffé P, Rickenbach M, Battegay M, Vernazza P, Nadal D, Speck R. Low Postseroconversion CD4 Count and Rapid Decrease of CD4 Density Identify HIV(+) Fast Progressors. AIDS Res Hum Retroviruses 2010; 26:997-1005.
01.09.2010Low Postseroconversion CD4 Count and Rapid Decrease of CD4 Density Identify HIV(+) Fast Progressors
01.09.2010AIDS Res Hum Retroviruses 2010; 26:997-1005
Audigé Annette, Taffé Patrick, Rickenbach Martin, Battegay Manuel, Vernazza Pietro, Nadal David, Speck Roberto F
Patients with influenza A/H1N1v- associated pneumonia: the perspective of a tertiary care hospital in Switzerland
Bertisch B, Vernazza P, Boggian K. Patients with influenza A/H1N1v- associated pneumonia: the perspective of a tertiary care hospital in Switzerland. Swiss Med Wkly 2010; 140:w13069.
15.07.2010Patients with influenza A/H1N1v- associated pneumonia: the perspective of a tertiary care hospital in Switzerland
15.07.2010Swiss Med Wkly 2010; 140:w13069
Bertisch Barbara, Vernazza Pietro, Boggian Katia
Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient
Hoffmann M, Tsinalis D, Vernazza P, Fierz W, Binet F. Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient. Swiss Med Wkly 2010; 140:286-92.
24.05.2010Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient
24.05.2010Swiss Med Wkly 2010; 140:286-92
Hoffmann Matthias, Tsinalis Dimitrios, Vernazza Pietro, Fierz W, Binet Françoise-Isabelle
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland
Kouyos R, Bonhoeffer S, Ledergerber B, Rickenbach M, Bernasconi E, Vernazza P, Battegay M, Furrer H, Cavassini M, Hirschel B, Weber R, Klimkait T, Bürgisser P, Shah C, Taffé P, Böni J, Yerly S, von Wyl V, Günthard H. Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. J Infect Dis 2010; 201:1488-97.
15.05.2010Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland
15.05.2010J Infect Dis 2010; 201:1488-97
Kouyos Roger D, Bonhoeffer Sebastian, Ledergerber Bruno, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Furrer Hansjakob, Cavassini Matthias, Hirschel Bernard, Weber Rainer, Klimkait Thomas, Bürgisser Philippe, Shah Cyril, Taffé Patrick, Böni Jürg, Yerly Sabine, von Wyl Viktor, Günthard Huldrych F
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir
Lubomirov R, Telenti A, Csajka C, Decosterd L, Buclin T, Descombes P, Rentsch K, Ledergerber B, Cavassini M, Calmy A, Vernazza P, Furrer H, Marzolini C, Martinez R, Colombo S, Fayet A, di Iulio J, Swiss HIV Cohort Study. ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir. Pharmacogenet Genomics 2010; 20:217-30.
01.04.2010ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir
01.04.2010Pharmacogenet Genomics 2010; 20:217-30
Lubomirov Rubin, Telenti Amalio, Csajka Chantal, Decosterd Laurent A, Buclin Thierry, Descombes Patrick, Rentsch Katharina, Ledergerber Bruno, Cavassini Matthias, Calmy Alexandra, Vernazza Pietro, Furrer Hansjakob, Marzolini Catia, Martinez Raquel, Colombo Sara, Fayet Aurélie, di Iulio Julia, Swiss HIV Cohort Study
Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection
Kovari H, Mueller N, Bernasconi E, Vernazza P, Foguena A, Hirschel B, Rauch A, Battegay M, Ledergerber B, Weber R. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010; 50:502-11.
15.02.2010Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection
15.02.2010Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010; 50:502-11
Kovari Helen, Mueller Nicolas J, Bernasconi Enos, Vernazza Pietro, Foguena Alain Kenfak, Hirschel Bernard, Rauch Andri, Battegay Manuel, Ledergerber Bruno, Weber Rainer
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008
Elzi L, Battegay M, Weber R, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Ledergerber B, Furrer H, Marzolini C, Swiss HIV Cohort Study. Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. Archives of internal medicine 2010; 170:57-65.
11.01.2010Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008
11.01.2010Archives of internal medicine 2010; 170:57-65
Elzi Luigia, Battegay Manuel, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Cavassini Matthias, Ledergerber Bruno, Furrer Hansjakob, Marzolini Catia, Swiss HIV Cohort Study
Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy
Bucher H, Battegay M, Weber R, Vernazza P, Schiffer V, Fux C, Cavassini M, Bernasconi E, Vallet Y, Glass T, Young J, Rickenbach M, the Swiss HIV Cohort Study. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antivir Ther 2010; 15:31-40.
01.01.2010Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy
01.01.2010Antivir Ther 2010; 15:31-40
Bucher Heiner C, Battegay Manuel, Weber Rainer, Vernazza Pietro, Schiffer Véronique, Fux Christoph, Cavassini Matthias, Bernasconi Enos, Vallet Yannick, Glass Tracy R, Young Jim, Rickenbach Martin, the Swiss HIV Cohort Study
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
Marzolini C, Battegay M, Back D, Ledergerber B, Khoo S, Vernazza P, Calmy A, Bernasconi E, Cavassini M, Chave J, Furrer H, Fux C, Weber R, Gibbons S, Elzi L, Swiss HIV Cohort Study. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antivir Ther (Lond) 2010; 15:413-23.
01.01.2010Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
01.01.2010Antivir Ther (Lond) 2010; 15:413-23
Marzolini Catia, Battegay Manuel, Back David, Ledergerber Bruno, Khoo Saye, Vernazza Pietro, Calmy Alexandra, Bernasconi Enos, Cavassini Matthias, Chave Jean-Philippe, Furrer Hansjakob, Fux Christoph, Weber Rainer, Gibbons Sara, Elzi Luigia, Swiss HIV Cohort Study
H1N1 pandemic: Watch out for the first wave in Switzerland
Vernazza P. H1N1 pandemic: Watch out for the first wave in Switzerland. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:730.
26.12.2009H1N1 pandemic: Watch out for the first wave in Switzerland
26.12.2009Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:730
Vernazza Pietro
Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study
Glass T, Bucher H, Günthard H, Rickenbach M, Bernasconi E, Hirschel B, Vernazza P, Furrer H, De Geest S, Cavassini M, Battegay M, the Swiss HIV Cohort Study. Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2009
23.12.2009Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study
23.12.2009Journal of acquired immune deficiency syndromes (1999) 2009
Glass Tracy R, Bucher Heiner C, Günthard Huldrych F, Rickenbach Martin, Bernasconi Enos, Hirschel Bernard, Vernazza Pietro, Furrer Hansjakob, De Geest Sabina, Cavassini Matthias, Battegay Manuel, the Swiss HIV Cohort Study